DEANA HAYS: Open Payments
NPI 1811187545 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 22 payments from 8 companies in 2025. Trend: 2023 $150 · 2024 $447 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $204 |
| Kestra Medical Technology Services, Inc. | 2 | $72 |
| PFIZER INC. | 3 | $52 |
| Boston Scientific Corporation | 1 | $34 |
| Amgen Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: LEQVIO, Assure WCD, VYNDAQEL, WATCHMAN FLX, Repatha, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ENTRESTO, ELIQUIS.
Industry payments across MI — which companies pay providers there.
